Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Involvement of position-147 for HLA-E expression.

Katsuyoshi Matsunami1, Tamiko Kusama, Eiji Okura

  • 1Division of Organ Transplantation, Department of Molecular Therepeutics, Osaka University Graduate School of Medicine, Japan.

Biochemical and Biophysical Research Communications
|July 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and Structural Elucidation of Phytochemicals from <i>Canarium luzonicum</i> Leaves and Evaluation of Anti-Lung Cancer and Antileishmanial Activity.

Molecules (Basel, Switzerland)·2026
Same author

Progress in immunological research on innate effectors in xenotransplantation.

Surgery today·2026
Same author

Present Advances and Emerging Challenges in Kidney Xenotransplantation.

Journal of clinical medicine·2026
Same author

A nitrogenated phenylpropanoid with cytotoxic and anti-Leishmanial activities from <i>Phalaris minor</i>.

Natural product research·2025
Same author

Current status and prospects of genetically modified porcine-to-human cardiac xenotransplantation.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2025
Same author

Differences between xenotransplantation and allogeneic kidney transplantation: the current situation and future challenges in Japan.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2025

A novel HLA-E variant, HLA-Ev(147), enhances cell surface expression and natural killer (NK) cell inhibition. This finding offers a promising gene tool for xenotransplantation therapies.

Area of Science:

  • Immunology
  • Transplantation Science
  • Molecular Biology

Background:

  • Human Leukocyte Antigen-E (HLA-E) is crucial for inhibiting natural killer (NK) cell cytolysis.
  • Restricted HLA-E cell surface expression, due to limited peptide binding, hinders its therapeutic application, especially in xenotransplantation.
  • Understanding HLA-E's molecular regulation is key to improving immune tolerance in transplantation.

Purpose of the Study:

  • To identify key amino acid positions regulating HLA-E cell surface expression.
  • To engineer an HLA-E variant with enhanced expression and function for xenotransplantation.
  • To evaluate the efficacy of the engineered HLA-E variant in a pig-to-human xenotransplantation model.

Main Methods:

  • Point substitutions were introduced into the HLA-E gene to assess effects on cell surface expression.

Related Experiment Videos

  • The Ser147Cys substitution (HLA-Ev(147)) was created, involving an oxygen-to-sulfur atom change.
  • In vitro assays were used to compare HLA-Ev(147) expression and inhibitory function against human NK cells versus wild-type HLA-E in a xenotransplantation model.

    • Main Results:

    • Position 147 was identified as critical for HLA-E cell surface expression.
    • The HLA-Ev(147) variant exhibited significantly higher cell surface expression on human and pig cells compared to wild-type HLA-E.
    • HLA-Ev(147) demonstrated enhanced inhibitory function against human NK cells in the xenotransplantation model.

    Conclusions:

    • The Ser147Cys substitution at position 147 is a key modification for enhancing HLA-E expression and function.
    • HLA-Ev(147) shows potential as a superior gene tool for improving outcomes in xenotransplantation.
    • This engineered HLA-E variant could mitigate NK cell-mediated rejection in future transplantation therapies.